Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Januzzi, J; Ferreira, JP; Böhm, M; Kaul, S; Wanner, C; Brueckmann, M; Petrie, MC; Ofstad, AP; Zeller, C; George, J; Fitchett, D; Zannad, F

Published Date

  • March 2019

Published In

Volume / Issue

  • 21 / 3

Start / End Page

  • 386 - 388

PubMed ID

  • 30767353

Pubmed Central ID

  • 30767353

Electronic International Standard Serial Number (EISSN)

  • 1879-0844

Digital Object Identifier (DOI)

  • 10.1002/ejhf.1419

Language

  • eng

Conference Location

  • England